Premalignant lesions: Current assessment of the clinical significance of atypical intraductal hyperplasia, lobular carcinoma in situ and ductal carcinoma in situ;Aktuelle bewertung des klinischen stellenwertes der ADH, des LCIS und des DCIS

Geburtshilfe und Frauenheilkunde

Volumn 63, Issue 3, 2003, Pages 271-272

  Gerber, Bernd ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; TAMOXIFEN;

BREAST CARCINOMA; BREAST DUCT; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CARCINOMA IN SITU; CLINICAL TRIAL; DIAGNOSTIC TEST; HUMAN; HYPERPLASIA; PRECANCER; SHORT SURVEY;

EID: 0037358838     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38471     Document Type: Short Survey

References (12)

1. Wickerham DL. J Clin Oncol 2001; 19: 98S-100S
2. Tavassoli FA. Virchows Arch 2001; 438: 221-227
3. Page DL et al. Lancet 2003; 361: 125-129
4. Ely KA et al. Am J Surg Pathol 2001; 25: 1017-1021
5. Wolmark N et al. Ann N Y Acad Sci 2001; 949: 99-108
6. Chan KC et al. Cancer 2001; 91: 9-16
7. Fisher B et al. Lancet 1999; 353: 1993-2000
8. Fisher B et al. J Clin Oncol 1998; 16: 441-452
9. Bijker N et al. J Clin Oncol 2001; 19: 2263-2271
10. Schwartz GF. Breast J 2001; 7: 308-310
11. Fisher B et al. Semin Oncol JID-0420432 2001;28:400-418
12. Allred DC et al. Breast Cancer Res Treat 2002;76:S36